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Abstract
Background: Systematic reviews (SRs) must be of high quality. The purpose of our research was to compare
the methodological and reporting quality of original versus updated Cochrane SRs to determine whether updating
had improved these two quality dimensions.
Methods: We identifed updated Cochrane SRs published in issue 4, 2002 of the Cochrane Library. We assessed
the updated and original versions of the SRs using two instruments: the 10 item enhanced Overview Quality
Assessment Questionnaire (OQAQ), and an 18-item reporting quality checklist and flow chart based upon the
Quality of Reporting of Meta-analyses (QUOROM) statement. At least two reviewers extracted data and
assessed quality. We calculated the percentage (with a 95% confidence interval) of 'yes' answers to each question.
We calculated mean differences in percentage, 95% confidence intervals and p-values for each of the individual
items and the overall methodological quality score of the updated and pre-updated versions using OQAQ.
Results: We assessed 53 SRs. There was no significant improvement in the global quality score of the OQAQ
(mean difference 0.11 (-0.28; 0.70 p = 0.52)). Updated reviews showed a significant improvement of 18.9 (7.2;
30.6 p < .01) on the OQAQ item assessing whether the conclusions drawn by the author(s) were supported by
the data and/or analysis presented in the SR. The QUOROM statement showed that the quality of reporting of
Cochrane reviews improved in some areas with updating. Improvements were seen on the items relating to data
sources reported in the abstract, with a significant difference of 17.0 (9.8; 28.7 p = 0.01), review methods,
reported in the abstract 35 (24.1; 49.1 p = 0.00), searching methods 18.9 (9.7; 31.6 p = 0.01), and data abstraction
18.9 (11.7; 30.9 p = 0.00).
Conclusion: The overall quality of Cochrane SRs is fair-to-good. Although reporting quality improved on certain
individual items there was no overall improvement seen with updating and methodological quality remained
unchanged. Further improvement of quality of reporting is possible. There is room for improvement of
methodological quality as well. Authors updating reviews should address identified methodological or reporting
weaknesses. We recommend to give full attention to both quality domains when updating SRs.
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Background
A number of papers have been published on the method-
ological and reporting quality of reviews. A review of 86
English language meta-analyses published between 1950
and 1986 by Sacks [1] assessed every report on fourteen
items covering six content areas believed to be critical in
the reporting of meta-analysis. Only 28% of these meta-
analyses were found to address all six content areas. An
updated survey in 1996 showed little change [2]. Shea [3]
compared the methodological quality of paper-based
and, electronic systematic reviews and found little differ-
ence and a lot of room for improvement. Assendelft [4]
reviewed 51 reviews and noted that reviews that favoured
a given intervention tended to have higher methodologi-
cal quality scores. In contrast, Jadad and McQuay [5]
reviewed 80 systematic reviews published between 1980
and 1992 and found a disconcerting link between reviews
whose results favoured an intervention and poor method-
ological quality. Jadad found that Cochrane reviews had
greater methodological rigor, more frequent updates and
higher overall quality scores than those published in peer-
reviewed paper journals, though both types were found to
contain extensive and serious flaws.
The Cochrane Collaboration [6] is an international not-
for-profit organization that conducts and updates system-
atic reviews of healthcare studies. With the exception of a
few studies completed by Jadad [7,8] and Shea [9], little is
known about the quality of Cochrane reviews and
whether their quality is improving over time and with
updating. To our knowledge, the impact of updating on
their quality has not been evaluated nor studied.
Studies of the quality of systematic reviews can focus on
methodological or reporting quality. Methodological
quality is concerned with how well a systematic review
was designed and conducted (e.g. literature searching,
pooling of data, etc.). Reporting quality considers how
well systematic reviewers have reported their methodol-
ogy and findings.
The purpose of our study was to compare the methodo-
logical and reporting quality of Cochrane systematic
reviews with that of their updated versions in order to
determine whether updating contributed significantly to
the improvement of their quality in these two dimen-
sions.
Methods
We selected all updated Cochrane systematic reviews from
the Cochrane Database of Systematic Reviews 2002 [10],
and the same reviews prior to their update. Updated
reviews were chosen following the definition of 'updating'
included in the Cochrane handbook [11].
Based on a previously published study [12], two instru-
ments chosen to assess the quality of Cochrane systematic
reviews for this study were the enhanced Overview Qual-
ity Assessment Questionnaire (OQAQ) scale [12-14]
(Additional File 1) and the Quality of Reporting of Meta-
analsyses (QUOROM) checklist [15] (Additional File 2).
The OQAQ was selected because it has strong face validity,
provided data on several essential elements of its develop-
ment, and had a published assessment of its construct
validity available [13]. In addition, its validity has been
thoroughly tested and established using a number of
independent measures [14]. However, we noted difficulty
applying the questions so we developed an enhanced ver-
sion of the OQAQ which incorporated guidelines for its'
use [12]. The OQAQ scale measures across a continuum
using nine questions (items 1–9) designed to assess vari-
ous aspects of the methodological quality of systematic
reviews and one overall assessment question (item 10).
When the scale is applied to a systematic review, the first
nine items are scored by selecting either yes, no, partial/
can't tell. The tenth item requires assessors to assign an
overall quality score on a 7-point scale [13].
The QUOROM statement was chosen for assessing report-
ing quality. Although, this checklist has not yet been fully
validated, extensive work has been conducted and
reported [15]. The QUOROM statement is comprised of a
checklist and flow diagram and was developed using a
consensus process designed to strengthen the reliability of
the estimates it yields when applied by different assessors.
It estimates the overall reporting quality of systematic
reviews. The checklist asks whether authors have provided
readers with information on 18 items, including searches,
selection, validity assessment, data abstraction, study
characteristics, quantitative data syntheses and trial flow.
It also asks whether authors have included a flow diagram
with information about the number of randomized con-
trolled trials identified, included and excluded, and the
reasons for any exclusion. Individual checklist items
included in this instrument are answered either yes, no
and partial/can't tell [15].
For each included Cochrane systematic review, we calcu-
lated the percentage (with a 95% confidence interval) of
'yes' answers to each item of OQAQ and QUOROM. Indi-
vidual Cochrane systematic reviews were then compared
to their updated versions with respect to the percentage of
'yes' ratings received. A percentage difference (with a 95%
confidence interval and p-values) of 'yes' answers was cal-
culated for each individual question. In addition, a mean
difference (with a 95% confidence interval and p-value)
was calculated for the overall quality score (OQAQ) of the
updated and pre-updated versions.BMC Medical Research Methodology 2006, 6:27 http://www.biomedcentral.com/1471-2288/6/27
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Assessments of all individual reviews were conducted
independently by at least two assessors. One of these
assessors (CH) had been involved with the Cochrane Col-
laboration for six years. The other assessor (BS) had been
involved with the Cochrane Collaboration for ten years,
and had carried out a number of systematic reviews. A
third assessor (DF) was available to assist in the resolution
of assessment discrepancies.
Results
In total, 53 reviews were included. The mean period
between the publication of the original and updated ver-
sions of the reviews was 2.7 years (range four months to
five years). Complete results for both instruments applied
to the reviews are provided in Tables 1 and 2, but high-
lights are summarized below.
OQAQ
Table 1 presents the methodological quality assessments
obtained using this scale. There was no significant differ-
ence in the global assessment (item 10 – How would you
rate the scientific quality of the overview?) (Mean score
original review 4.70, mean score updated review 4.81, dif-
ference in means 0.11 (95% CI -0.28; 0.70 p = 0.52)).
There were improvements on seven individual items,
although only one item showed a significant improve-
ment (item 9 – Were the conclusions made by the
author(s) supported by the data and/or analysis reported
in the overview?) (percent original reviews complying
with item 76% (95% CI 4.47; 4.94) percentage updated
reviews complying with item 94% (95% 88.1; 100.0) dif-
ference 18.9% (95% CI 7.2%; 30.6% p < 0.01)).
QUOROM
Table 2 presents the assessments of reporting quality
obtained using the Quality of Reviews of Meta-analyses
(QUOROM) checklist. Scores (awarded for 'yes' response)
on the 18 items for original Cochrane reviews ranged
from 0% (item 1) to 100% (items 2 and 18). Four of the
18 items revealed improvements relating to data sources
reported in the abstract (item 4) with a significant differ-
ence of 17.0% (9.8; 28.7 p = 0.01), review  methods
reported in the abstract (item 5) with a difference of 35%
(24.1; 49.1 p = 0.00), searching methods (item 9) with a
difference of 18.9% (9.7; 31.6 p = 0.01), and data abstrac-
tion (item 12) with a difference of 18.9% (11.7; 30.9 p =
0.00).
Three questions, item (10) -3.7% (95% CI: -9.0; 3.8 p =
0.15), item (14) -3.7% (-14.8; 6.4 p = 0.62) and item (16),
-5.7% (-15.8; 3.0 p = 0.40) had lower mean scores on
updated reviews than on original reviews, but these differ-
ences were not statistically significant.
Discussion
In assessing the quality of the sample of 53 systematic
reviews of the Cochrane Collaboration, two assessment
tools were used. The larger improvement on the
QUOROM checklist than on the OQAQ suggests that
although the quality of reporting has improved slightly,
the quality of design and conduct has not changed. For
example, the items in reporting of selection criteria and
searching are improved on QUOROM, but the equivalent
items on OQAQ, which relate to how well these were car-
ried out have not changed.
The significant improvements for the OQAQ item assess-
ing whether the conclusions drawn by the author(s) were
supported by the data and/or analysis reported in the
overview is also worthy of note. This could suggest that
authors are paying more attention to state their conclu-
sion in relation to the data provided. This item has been
reported by other methodologists in the context of asess-
ing quality [16,17].
Improvement in the quality of reporting of the abstract, as
assessed by the QUOROM instrument, might also suggest
that authors are paying more attention to the details. For
example, authors might be more aware of better access to
the Cochrane abstracts through electronic systems such as
Medline. Also, reporting of literature searches improved.
However, the literature searches themselves did not
improve. This should be further explored.
Assessors expressed that they found the two instruments
used in the study to have associated practical weaknesses.
Their combined length (28 items) made their use some-
what cumbersome and inefficient. Another problem
encountered was the lack of adequate published guidance
on the application of the OQAQ question, assessing the
overall methodological quality. The QUOROM checklist
had the advantage of coming with fairly detailed user
instructions. However, it proved very time-consuming to
apply [12]. Another problem noted was that several of the
questions asked by these two instruments appeared to
cover the same subject matter.
The methodological and reporting quality of Cochrane
reviews was fair-to-good, but further improvement is
obviously needed in both areas. This was also concluded
in a recent study by Moja [16]. In addition, the quality-
improvement impact of updating was found to be rela-
tively minor. On some assessed factors, particularly with
respect to reporting quality, updated reviews actually
scored lower than original reviews. Currently, Cochrane
review updates are carried out primarily to incorporate
new findings, rather than to improve quality. It would be
beneficial for updates to also address reporting, such as
the omission of methodological descriptions. And ofB
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Table 1: Comparisons of percent 'yes' and percent 'differences' using the enhanced Overview Quality Assessment Questionnaire (OQAQ).
Questions OQAQ Original Reviews yes, % 
reviews yes
[95% CI]
Updated Reviews yes, % 
reviews yes
[95% CI]
Difference % Yes
[95% CI] p-value
1. Were the search methods used to find evidence reported? 81% [68.9 to 93.4] 87% [75.7 to 97.9] 5.7% [-6.6 to 17.9] 0.43
2. Was the search strategy for evidence reasonably comprehensive? 68% [47.0 to 88.7] 70% [48.3 to 91.3] 1.9% [-19.0 to 22.8] 0.83
3. Were the criteria used for deciding which studies to include in the overview reported? 98% [94.4 to 100.0] 91% [80.5 to 100.0] -7.6% [-11.2 to 3.9] 0.09
4. Was bias in the selection of studies avoided? 64% [45.4 to 82.8] 70% [52.0 to 87.6] 5.7% [-13.1 to 24.4] 0.53
5. Were criteria used for assessing validity of the included studies reported? 89% [73.7 to 100.0] 96% [85.9 to 100.0] 7.6% [-7.4 to 22.5] 0.14
6. Was the validity of all studies referred to in the text assessed using appropriate criteria (either 
in selecting studies for inclusion or in analyzing studies that are cited)?
85% [70.6 to 99.2] 93% [82.9 to 100.0] 7.6% [-0.68 to 21.9] 0.22
7. Were methods used to combine the findings of relevant studies (to reach a conclusion) 
reported?
89% [66.2 to 99.8] 83% [71.5 to 100.0] -5.7% [-022.9 to 11.6] 0.40
8. Were findings of the relevant studies combined appropriately relative to the primary question 
addressed?
87% [68.4 to 100.0] 91% [78.7 to 100.0] 3.8% [-14.6 to 22.2] 0.54
9. Were the conclusions made by the author (s) supported by the data and/or analysis reported in 
the overview?
76% [63.8 to 87.2] 94% [88.1–100.0] 18.9% [7.2 to 30.6] 0.01
10. How would you rate the scientific quality of this overview? 4.70 [4.47 to 4.94] 4.81 [4.59 to 5.04] 0.11 [-.28 to .70] 0.52B
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Table 2: Comparisons of percent 'yes' and percent 'differences' using the Quality of Reporting of Meta-analyses (QUOROM).
Questions QUOROM Original Updated Difference
Items Heading Subheading Descriptor Reviews yes, % 
reviews yes
[95% CI]
Reviews yes, % 
reviews yes
[95% CI]
Difference %
[95% CI] p-value
1 Title Identified the report as a meta-analysis [or systematic review] of randomized trials. 0, 0% 0, 0% 0% NS
2A b s t r a c t Used a structured format. 100% 100% 0% NS
3 Objectives The clinical question explicitly. 96.2% [91.0 to 100.0] 98% [94.4 to 100.0] 1.9% [-1.8 to 7.0] 0.56
4 Data sources The databases (e.g. list) and other information sources. 76% [63.8 to 87.2] 93% [85.3 to 99.6] 17.0% [9.8 to 28.7] 0.01
5 Review 
methods
The selection criteria (e.g. population, intervention, outcome, and study design; methods for 
validity assessment, data abstraction, and study characteristics, and quantitative data 
synthesis) in sufficient detail to permit replication.
40% [26.3 to 52.9] 76% [63.8 to 87.2] 35.9% [24.1 to 49.1] 0.00
6 Results Characteristics of the randomized trials included and excluded; qualitative and quantitative 
findings (e.g. point estimates and confidence intervals); and subgroup analyses.
71% [59.5 to 83.9] 77% [66.0 to 88.7] 5.7% [-5.7 to 17.9] 0.50
7 Conclusion The main results. 96% [91.4 to 100.0] 98% [94.4 to 100.0] 1.9% [-1.8 to 7.1] 0.56
8 Intro The explicit clinical problem, biologic rationale for the intervention, and rationale for review. 98% [94.4 to 100.0] 100% 2% [1.9 to 5.6] 0.31
9 Methods Searching The information sources, in detail (e.g., databases, registers, personal files, expert 
informants, agencies, hand-searching], and any restrictions (e.g. years considered, publication 
status, language of publication).
68% [55.2 to 80.6] 87% [77.7 to 96.0] 18.9% [9.7 to 31.6] 0.02
10 Selection The inclusion and exclusion criteria (defining population, intervention principal outcomes, 
and study design).
100% 96% [91.0 to 100.0] -3.7% [-9.0 to 3.8] 0.15
11 Validity 
assessment
The criteria and process used [e.g., masked conditions, quality assessment and their findings. 87% [77.6 to 96.0] 96% [91.0 to 100.0] 9.4% [4.3 to 18.6] 0.08
12 Data 
abstraction
The process used (e.g., completed independently, in duplicate). 74% [61.6 to 85.6] 93% [85.3 to 99.6] 18.9% [11.7 to 30.9] 0.01
13 Study 
characteristics
The type of study design, participants' characteristics, details of intervention, outcome 
definitions, etc.; and how clinical heterogeneity was assessed.
89% [61.6 to 85.6] 96% [91.0 to 100.0] 7.6% [2.4 to 16.1] 0.14
14 Quantitative 
data synthesis
The principal measures of effect [e.g., relative risk], method of combining results (statistical 
testing and confidence intervals), handling of missing data, etc.; how statistical heterogeneity 
was assessed; a rationale for any a priori sensitivity and subgroup analyses; and any 
assessment of publication bias.
83% [72.8 to 93.2] 79% [68.2 to 90.2] -3.7% [-14.8 to 6.4] 0.62
15 Results Trial flow Provide a meta-analysis profile summarizing trial flow 2% [-1.8 to 5.6] 8% [0.36 to 14.7] 5.7% [-1.5 to 9.4] 0.17
16 Study 
characteristics
Present descriptive data for each trial [e.g., age, sample size, intervention, dose, and duration, 
follow-up].
89% [80.1 to 97.3] 83% [72.9 to 93.2] -5.7% [-15.9 to 2.9] 0.40
17 Quantitative 
data synthesis
Report agreement on the selection and validity assessment; present simple summary results 
[for each treatment group in each trial, for each primary outcome]; data needed to calculate 
effect sizes and confidence intervals in intention-to-treat analyses [e.g., 2 × 2 tables of 
counts, means and standard deviations, proportions].
81% [70.5 to 91.8] 89% [80.1 to 97.3] 7.5 [-1.1 to 18.2] 0.28
18 Discussion Summarize the key findings; discuss clinical inferences based on internal and external validity; 
interpret the results in light of the totality of available evidence; describe potential biases in 
the review process [e.g., publication bias]; and suggest a future research agenda.
96% [91.0 to 100.0] 96% [91.0 to 100.0] 0% [-5.2 to 5.2] NSBMC Medical Research Methodology 2006, 6:27 http://www.biomedcentral.com/1471-2288/6/27
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course, updates should also try to improve methodologi-
cal weaknesses of the reviews.
The Cochrane Collaboration endeavours to improve the
quality of its systematic reviews through the application of
a continuous peer review process during their develop-
ment. The effectiveness of the peer-review process could
probably be improved by increased attention to areas of
reporting and/or methodological weaknesses. Reviewers
should adhere more faithfully to the guidelines provided
in the Cochrane handbook [17] in order to improve the
design and conduct of reviews and to the QUOROM state-
ment [15] to improve the quality of reporting of system-
atic reviews.
Conclusion
The overall quality of Cochrane reviews is fair-to-good.
Although quality of reporting improved on certain indi-
vidual items there was no overall improvement seen with
updating and methodological quality remained
unchanged. Further improvement of quality of reporting
is possible. There is room for improvement of methodo-
logical quality as well. Authors updating reviews should
address identified methodological or reporting weak-
nesses. We recommend to give full attention to both qual-
ity domains when updating SRs.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
BS designed the protocol and the study, abstracted the
data, conducted the analysis, and wrote the paper; MB
designed the protocol and the study, and assisted with
writing the paper; JMG provided intellectual input into
the design and conduct of the study, and assisted with
writing the paper; CH carried out the data abstraction,
quality assessment and assisted with the analysis; LMB
provided intellectual input into the design and conduct of
the study, and assisted with writing the paper.
Additional material
Acknowledgements
The authors would like to acknowledge Daniel Francis for his assistance 
with the quality assessment, Ron Habinski, Ashley Porter and Crystal 
Huntly-Ball for their comments on earlier drafts of this paper; David Moher 
for his methodological recommendations; Tim Ramsey for his statistical 
advice, and our external reviewer Penny Whiting for her helpful sugges-
tions.
References
1. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC:
Meta-analyses of randomized controlled trials.  N Engl J Med
1987, 316:450-5.
2. Sacks HS, Reitman D, Pagano D, Kupelnick B: Meta-analysis: an
update.  Mount Sinai Journal of Medicine 1996, 63:216-24.
3. Shea B: Assessing the quality of reporting meta-analyses of
randomized controlled trials.  In MSc thesis University of Ottawa,
Department of Epidemiology and Community Medicine; 1999. 
4. Assendelft WJJ, Koes BW, Knipschild PG, Bouter LM: The relation-
ship between methodological quality and conclusions in
reviews of spinal manipulation.  JAMA 1995, 274:1942-1948.
5. Jadad AR, McQuay HJ: Meta-analyses to evaluate analogies
interventions: a systematic qualitative review of their meth-
odology.  J Clin Epidemiol 1996, 49:235-43.
6. The Cochrane Collaboration   [http://www.cochrane.org/]
7. Jadad AR, Cook DJ, Jones A, Klassen TP, Tugwell P, Moher M, Moher
D: Methodology and reports of systematic reviews and meta-
analyses: a comparison of Cochrane reviews with articles
published in paper-based journals.  JAMA 1998, 280:278-280.
8. Jadad AR, Moher M, Brownman GP, Booker L, Sigouin C, Fuentes M,
Stevens R: Systematic reviews and meta-analyses on treat-
ment of asthma: critical evaluation.  BMJ 2000, 320:537-540.
9. Shea B, Moher D, Graham I, Pham B, Tugwell P: A comparison of
the quality of reporting of Cochrane review and systematic
reviews published in paper-based journals.  Evaluations and the
Health Professions 2002, 25:116-129.
10. The Cochrane Library Issue 4 Chichester, UK: John Wiley & Sons, Ltd;
2002. 
11. Clarke M, Oxman AD, editors: Cochrane Reviewers' Handbook.
In The Cochrane Library Issue 2 UK: Update Softeware; 2002. 
12. Shea B, Dube C, Moher D: Assessing the quality of reports of
systematic reviews: the QUOROM statement compared to
other tools.  In Systematic reviews in health care: meta-analysis in con-
text Edited by: Egger M, Smith GD, Altman DG. London, UK: BMJ Pub-
lishing Group; 2001:122-39. 
13. Oxman AD, Guyatt GH: Validation of an index of the quality of
review articles.  J Clin Epidemiol 1991, 44:1271-8.
14. Oxman AD: Checklists for review articles.  BMJ 1994,
309:648-651.
15. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF:
Improving the quality of reports of meta-analyses of rand-
omized controlled trials: the QUOROM statement. Quality
of reporting of meta-analyses.  Lancet 1999, 354:1896-900.
16. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, Liberati A, on
behalf of the Metaquality Study Group: Assessment of methodo-
logical quality of primary studies by systematic review:
results of the metaquality cross sectional study.  BMJ 2005,
330:1053-1058.
17. The Cochrane Library Issue 4 Chichester, UK: John Wiley & Sons, Ltd;
2005. 
Additional File 1
The enhanced version of the overview quality assessment questionnaire 
(OQAQ).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2288-6-27-S1.doc]
Additional File 2
Quality of reporting of meta-analyses (QUOROM) for randomized con-
trolled trials.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2288-6-27-S2.doc]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medical Research Methodology 2006, 6:27 http://www.biomedcentral.com/1471-2288/6/27
Page 7 of 7
(page number not for citation purposes)
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2288/6/27/prepub